PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of annrheumdAnnals of the Rheumatic DiseasesCurrent TOCInstructions for authors
 
Ann Rheum Dis. Nov 1990; 49(11): 916–920.
PMCID: PMC1004262
Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.
D M van der Heijde, M A van 't Hof, P L van Riel, L A Theunisse, E W Lubberts, M A van Leeuwen, M H van Rijswijk, and L B van de Putte
Department of Rheumatology, University Hospital, Nijmegen, The Netherlands.
Abstract
An investigation of clinical and laboratory variables which might form the basis for judging disease activity in clinical practice was made by six rheumatologists in a prospective study of up to three years' duration of 113 patients with early rheumatoid arthritis. Decisions to start treatment with slow acting antirheumatic drugs were equated with moments of high disease activity. If treatment with slow acting antirheumatic drugs was not started or if the slow acting antirheumatic drug remained unchanged for at least one year or if treatment was stopped because of disease remission, this was equated with periods of low disease activity. Two groups, one with high and one with low disease activity according to the above criteria, were formed. Factor analysis was performed to enable easy handling of the large number of clinical and laboratory variables without loss of information; this resulted in five factors. Next, discriminant analysis was done to determine to what extent each factor contributed to discrimination between the two groups of differing disease activity. Finally, a multiple regression analysis was carried out to determine which laboratory and clinical variables underlie the factors of the discriminant function, resulting in a 'disease activity score'. This score consisted of the following variables: Ritchie index, swollen joints, erythrocyte sedimentation rate, and general health, in declining importance. The rheumatologists' decisions to prescribe slow acting antirheumatic drugs, or not, were mainly based on articular symptoms.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (962K), or click on a page image below to browse page by page.
Articles from Annals of the Rheumatic Diseases are provided here courtesy of
BMJ Group